Stock RVNC REVANCE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Revance Therapeutics, Inc.

Equities

RVNC

US7613301099

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
3.4 USD +3.34% Intraday chart for Revance Therapeutics, Inc. -10.05% -61.32%
Apr. 26 AbbVie raises annual profit forecast on strong Skyrizi sales RE
Apr. 12 Revance Therapeutics, Inc. to Present New DAXXIFY Data at the American Academy of Neurology 2024 Annual Meeting CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. RVNC Stock
  4. Revisions Revance Therapeutics, Inc.